1998 and Year 2000 Updates of a National Survey of Prescription Drug Information Provided to Patients

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
5848	1998 and Year 2000 Updates of a National Survey of Prescription Drug Information Provided to Patients	Migrated

ICR Details

OMB Control No: 0910-0279	ICR Reference No: 199807-0910-004
Status: Historical Active	Previous ICR Reference No: 199803-0910-008
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: 1998 and Year 2000 Updates of a National Survey of Prescription Drug Information Provided to Patients
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/16/1998
	Date Received in OIRA: 07/16/1998
Terms of Clearance: This collection is approved for the 1998 data collection only on the following conditions: FDA shall take additional steps to significantly increase the response rates as outlined in FDA's addendum to the package -- Statement Regarding Response Rate. In addition, FDA shall report to OMB at the time of the next submission the response rates obtained from the 1998 collection. Because it is critical that these response rates increase, the response rates from the 1998 collection must be sufficiently high to obtain approval of this collection in future years.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	05/31/1999	05/31/1999	08/31/1998
Responses	667	0	9,142
Time Burden (Hours)	434	0	467
Cost Burden (Dollars)	0	0	0

---

Abstract: Since 1992, FDA has surveyed the public periodically regarding health professional counseling of patients about prescription medications, distribution of written medication information, and patient-initiated information-seeking about medications. This tracking study was conducted in 1982, 1984, 1992, 1994, and 1996. It is essential for FDA to continue to conduct this survey in 1998 and 2000 because: (1) FDA is responsible for objective 12.8 within the national DHHS Healthy People 2000 initiative to assess an increase in patient medication counseling levels to 75 percent and (2) Public Law 104-80 (Effective....

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
1998 and Year 2000 Updates of a National Survey of Prescription Drug Information Provided to Patients

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	667	9,142	0	0	-8,475	0
Annual Time Burden (Hours)	434	467	0	0	-33	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/16/1998

---